Cargando…
Response to Comment on: Lassenius et al. Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation. Diabetes Care 2011;34:1809–1815
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263912/ http://dx.doi.org/10.2337/dc11-2085 |
| _version_ | 1782221949721640960 |
|---|---|
| author | Lassenius, Mariann I. Pussinen, Pirkko J. Forsblom, Carol Groop, Per-Henrik Lehto, Markku |
| author_facet | Lassenius, Mariann I. Pussinen, Pirkko J. Forsblom, Carol Groop, Per-Henrik Lehto, Markku |
| author_sort | Lassenius, Mariann I. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3263912 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-32639122013-02-01 Response to Comment on: Lassenius et al. Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation. Diabetes Care 2011;34:1809–1815 Lassenius, Mariann I. Pussinen, Pirkko J. Forsblom, Carol Groop, Per-Henrik Lehto, Markku Diabetes Care Diabetes Care Electronic Pages American Diabetes Association 2012-02 2012-01-16 /pmc/articles/PMC3263912/ http://dx.doi.org/10.2337/dc11-2085 Text en © 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
| spellingShingle | Diabetes Care Electronic Pages Lassenius, Mariann I. Pussinen, Pirkko J. Forsblom, Carol Groop, Per-Henrik Lehto, Markku Response to Comment on: Lassenius et al. Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation. Diabetes Care 2011;34:1809–1815 |
| title | Response to Comment on: Lassenius et al. Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation. Diabetes Care 2011;34:1809–1815 |
| title_full | Response to Comment on: Lassenius et al. Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation. Diabetes Care 2011;34:1809–1815 |
| title_fullStr | Response to Comment on: Lassenius et al. Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation. Diabetes Care 2011;34:1809–1815 |
| title_full_unstemmed | Response to Comment on: Lassenius et al. Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation. Diabetes Care 2011;34:1809–1815 |
| title_short | Response to Comment on: Lassenius et al. Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation. Diabetes Care 2011;34:1809–1815 |
| title_sort | response to comment on: lassenius et al. bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. diabetes care 2011;34:1809–1815 |
| topic | Diabetes Care Electronic Pages |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263912/ http://dx.doi.org/10.2337/dc11-2085 |
| work_keys_str_mv | AT lasseniusmarianni responsetocommentonlasseniusetalbacterialendotoxinactivityinhumanserumisassociatedwithdyslipidemiainsulinresistanceobesityandchronicinflammationdiabetescare20113418091815 AT pussinenpirkkoj responsetocommentonlasseniusetalbacterialendotoxinactivityinhumanserumisassociatedwithdyslipidemiainsulinresistanceobesityandchronicinflammationdiabetescare20113418091815 AT forsblomcarol responsetocommentonlasseniusetalbacterialendotoxinactivityinhumanserumisassociatedwithdyslipidemiainsulinresistanceobesityandchronicinflammationdiabetescare20113418091815 AT groopperhenrik responsetocommentonlasseniusetalbacterialendotoxinactivityinhumanserumisassociatedwithdyslipidemiainsulinresistanceobesityandchronicinflammationdiabetescare20113418091815 AT lehtomarkku responsetocommentonlasseniusetalbacterialendotoxinactivityinhumanserumisassociatedwithdyslipidemiainsulinresistanceobesityandchronicinflammationdiabetescare20113418091815 AT responsetocommentonlasseniusetalbacterialendotoxinactivityinhumanserumisassociatedwithdyslipidemiainsulinresistanceobesityandchronicinflammationdiabetescare20113418091815 |